Black Rock Inc. Imago Bio Sciences, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$15.03 - $35.96 $3.29 Million - $7.87 Million	218,820 Added 5.13%	4,480,897 $161 Million
Q3 2022 Nov 14, 2022	BUY	$14.15 - $19.5 $2.77 Million - $3.82 Million	196,000 Added 4.82%	4,262,077 $64.1 Million
Q2 2022 Aug 12, 2022	BUY	$11.81 - $20.92 $9.15 Million - $16.2 Million	775,183 Added 23.56%	4,066,077 $54.4 Million
Q1 2022 May 12, 2022	BUY	$16.97 - $25.0 $33.2 Million - $48.9 Million	1,954,112 Added 146.18%	3,290,894 $63.4 Million
Q4 2021 Feb 10, 2022	BUY	$16.22 - $29.69 $3.44 Million - $6.3 Million	212,289 Added 18.88%	1,336,782 $31.7 Million
Q3 2021 Nov 09, 2021	BUY	$16.0 - $28.84 $18 Million - $32.4 Million	1,124,493 New	1,124,493 $22.5 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.